Precision medicine in epilepsy: ‘Don’t raise patient expectations’
A real-world study across six specialist centres suggests genetic testing leads to therapeutic improvements in only a small minority of patients
Precision medicine in epilepsy has a long way to go before it can reliably be expected to produce therapeutic benefits in the way that is being seen in oncology, leading neurologists say.
In fact, therapy changes that are not rationally based on genetic testing results seem to be more effective than those that are, a study suggests.
